What's new

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised

Mar 27, 2025 - 15:01
 0
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

HHS to cut 10,000 staff in major restructuring under RFK Jr.

Next Article

Ermenegildo Zegna Group: Annual profit falls by one-third

Related Posts

Human medicines European public assessment report (EPAR): Duloxetine Viatris (previously Duloxetine Mylan), duloxetine, Date of authorisation: 19/06/2015, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

User guide for micro, small and medium-sized enterprises

Mar 14, 2025  0

Orphan designation: epertinib Treatment of amyotrophic lateral sclerosis, 26/02/2025 Positive

Orphan designation: epertinib Treatment of amyotrophic ...

Mar 11, 2025  0